127 related articles for article (PubMed ID: 38471488)
21. The antimicrobial peptide cathelicidin enhances activation of lung epithelial cells by LPS.
Shaykhiev R; Sierigk J; Herr C; Krasteva G; Kummer W; Bals R
FASEB J; 2010 Dec; 24(12):4756-66. PubMed ID: 20696857
[TBL] [Abstract][Full Text] [Related]
22. Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37.
Mookherjee N; Brown KL; Bowdish DM; Doria S; Falsafi R; Hokamp K; Roche FM; Mu R; Doho GH; Pistolic J; Powers JP; Bryan J; Brinkman FS; Hancock RE
J Immunol; 2006 Feb; 176(4):2455-64. PubMed ID: 16456005
[TBL] [Abstract][Full Text] [Related]
23. TGF-beta1 induced epithelial to mesenchymal transition (EMT) in human bronchial epithelial cells is enhanced by IL-1beta but not abrogated by corticosteroids.
Doerner AM; Zuraw BL
Respir Res; 2009 Oct; 10(1):100. PubMed ID: 19857272
[TBL] [Abstract][Full Text] [Related]
24. Green tea polyphenol epigallocatechin-3-gallate and cranberry proanthocyanidins act in synergy with cathelicidin (LL-37) to reduce the LPS-induced inflammatory response in a three-dimensional co-culture model of gingival epithelial cells and fibroblasts.
Lombardo Bedran TB; Palomari Spolidorio D; Grenier D
Arch Oral Biol; 2015 Jun; 60(6):845-53. PubMed ID: 25791329
[TBL] [Abstract][Full Text] [Related]
25. Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37, resulting in altered activities.
Kilsgård O; Andersson P; Malmsten M; Nordin SL; Linge HM; Eliasson M; Sörenson E; Erjefält JS; Bylund J; Olin AI; Sørensen OE; Egesten A
Am J Respir Cell Mol Biol; 2012 Feb; 46(2):240-8. PubMed ID: 21960546
[TBL] [Abstract][Full Text] [Related]
26. The antimicrobial peptide LL-37 enhances IL-8 release by human airway smooth muscle cells.
Zuyderduyn S; Ninaber DK; Hiemstra PS; Rabe KF
J Allergy Clin Immunol; 2006 Jun; 117(6):1328-35. PubMed ID: 16750994
[TBL] [Abstract][Full Text] [Related]
27. Human host defense peptide LL-37 facilitates double-stranded RNA pro-inflammatory signaling through up-regulation of TLR3 expression in vascular smooth muscle cells.
Dahl S; Cerps S; Rippe C; Swärd K; Uller L; Svensson D; Nilsson BO
Inflamm Res; 2020 Jun; 69(6):579-588. PubMed ID: 32221618
[TBL] [Abstract][Full Text] [Related]
28. Human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure.
Shaykhiev R; Beisswenger C; Kändler K; Senske J; Püchner A; Damm T; Behr J; Bals R
Am J Physiol Lung Cell Mol Physiol; 2005 Nov; 289(5):L842-8. PubMed ID: 15964896
[TBL] [Abstract][Full Text] [Related]
29. TNF-α-mediated bronchial barrier disruption and regulation by src-family kinase activation.
Hardyman MA; Wilkinson E; Martin E; Jayasekera NP; Blume C; Swindle EJ; Gozzard N; Holgate ST; Howarth PH; Davies DE; Collins JE
J Allergy Clin Immunol; 2013 Sep; 132(3):665-675.e8. PubMed ID: 23632299
[TBL] [Abstract][Full Text] [Related]
30. Diallyl disulfide inhibits ethanol-induced pulmonary cell vitamin D and antimicrobial peptide cathelicidin depletion.
Ogunsakin O; Sriyotha P; Burns T; Hottor T; McCaskill M
Alcohol; 2019 Nov; 80():99-108. PubMed ID: 30580017
[TBL] [Abstract][Full Text] [Related]
31. Cathelicidin LL-37 increases lung epithelial cell stiffness, decreases transepithelial permeability, and prevents epithelial invasion by Pseudomonas aeruginosa.
Byfield FJ; Kowalski M; Cruz K; Leszczyńska K; Namiot A; Savage PB; Bucki R; Janmey PA
J Immunol; 2011 Dec; 187(12):6402-9. PubMed ID: 22095714
[TBL] [Abstract][Full Text] [Related]
32. German cockroach proteases regulate matrix metalloproteinase-9 in human bronchial epithelial cells.
Page K; Hughes VS; Bennett GW; Wong HR
Allergy; 2006 Aug; 61(8):988-95. PubMed ID: 16867053
[TBL] [Abstract][Full Text] [Related]
33. The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system.
Barlow PG; Li Y; Wilkinson TS; Bowdish DM; Lau YE; Cosseau C; Haslett C; Simpson AJ; Hancock RE; Davidson DJ
J Leukoc Biol; 2006 Sep; 80(3):509-20. PubMed ID: 16793910
[TBL] [Abstract][Full Text] [Related]
34. The human cathelicidin LL-37 enhances airway mucus production in chronic obstructive pulmonary disease.
Zhang Y; Jiang Y; Sun C; Wang Q; Yang Z; Pan X; Zhu M; Xiao W
Biochem Biophys Res Commun; 2014 Jan; 443(1):103-9. PubMed ID: 24291709
[TBL] [Abstract][Full Text] [Related]
35. The antimicrobial peptide LL-37 induces synthesis and release of cysteinyl leukotrienes from human eosinophils--implications for asthma.
Sun J; Dahlén B; Agerberth B; Haeggström JZ
Allergy; 2013 Mar; 68(3):304-11. PubMed ID: 23330796
[TBL] [Abstract][Full Text] [Related]
36. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium.
Hase K; Eckmann L; Leopard JD; Varki N; Kagnoff MF
Infect Immun; 2002 Feb; 70(2):953-63. PubMed ID: 11796631
[TBL] [Abstract][Full Text] [Related]
37. Intracellular receptor for human host defense peptide LL-37 in monocytes.
Mookherjee N; Lippert DN; Hamill P; Falsafi R; Nijnik A; Kindrachuk J; Pistolic J; Gardy J; Miri P; Naseer M; Foster LJ; Hancock RE
J Immunol; 2009 Aug; 183(4):2688-96. PubMed ID: 19605696
[TBL] [Abstract][Full Text] [Related]
38. LIGHT is a crucial mediator of airway remodeling.
Hung JY; Chiang SR; Tsai MJ; Tsai YM; Chong IW; Shieh JM; Hsu YL
J Cell Physiol; 2015 May; 230(5):1042-53. PubMed ID: 25251281
[TBL] [Abstract][Full Text] [Related]
39. Differential regulation of human cathelicidin LL-37 by free fatty acids and their analogs.
Jiang W; Sunkara LT; Zeng X; Deng Z; Myers SM; Zhang G
Peptides; 2013 Dec; 50():129-38. PubMed ID: 24140860
[TBL] [Abstract][Full Text] [Related]
40. Cathelicidin and Calprotectin Are Disparately Altered in Murine Models of Inflammatory Arthritis and Airway Inflammation.
Hemshekhar M; Piyadasa H; Mostafa D; Chow LNY; Halayko AJ; Mookherjee N
Front Immunol; 2020; 11():1932. PubMed ID: 32973796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
